Purpose: To develop methods to delineate the relationship between endothelial cell toxicity and tissue fixation (toxicity/fixation) using sodium hydroxymethylglycinate (SMG), a formaldehyde releaser, and riboflavin-UVA photochemical corneal cross-linking (CXL) for therapeutic tissue cross-linking of the cornea.
C XL has revolutionized corneal therapeutics. [1] [2] [3] Although interest and use continue to expand, CXL remains an investigational procedure in the United States and many questions remain regarding CXL from a clinical and basic science perspective. The use of UV light in the cross-linking process has been a concern from the outset of the US clinical trials, which underscores the potential hazard of using the current cross-linking method. It also highlights a potential benefit of alternative topical methods for cross-linking. That is, UV light may not be necessary. UV light exposure to the eye has been implicated in a number of deleterious effects, including damage to the lens 4 and retina, 5 and as such, the long-term effects are difficult to predict. Regarding corneal cytotoxicity, although damage to stromal keratocytes is known to occur, the effects on corneal endothelial cells have been debated. Increased endothelial damage with CXL has been reported for both in vivo and in vitro studies. 6, 7 In a clinical study, the application of CXL to human corneas less than 400 mm thick resulted in some toxicity to the endothelium. 8, 9 Most keratoconic patients are young, and because human corneal endothelial cells do not have regenerative capacity, 10 endothelial preservation is critical. Providing corneal stabilization without exposing patients to UV light could remove a potential hazard of the treatment.
Sodium hydroxymethylglycinate (SMG) is a small water-soluble compound (molecular weight = 127) and is one of a group of formaldehyde releasers, recently introduced for therapeutic tissue cross-linking (TXL) of the cornea. Formaldehyde releasers are used as preservatives in a wide array of popular cosmetic and personal care products, 11 such as skin care products, body wash, fingernail polish, and shampoo. Formaldehyde releasers have also been used in the textile industry as cross-linking agents to impart antiwrinkle properties to clothing. 12 In a recent study, we reported SMG to be highly effective as a corneal stiffening agent in ex vivo rabbit eyes with in vitro toxicity threshold less than 0.1 mM, on par with previously studied higher order nitroalcohols. 13 The current study is an extension of the previous work in which we evaluate the efficacy and safety of corneal crosslinking with SMG, comparing it with CXL in an ex vivo rabbit model. Our intent was to identify the optimal concentration of chemical agents that can effectively cross-link collagen with minimal to no effect on endothelial cell viability. These studies lay the groundwork for future studies using live animals.
METHODS AND MATERIALS
Chemicals SMG, hydroxypropyl methylcellulose (HPMC, 15 cP), dextran (high molecular weight = 425,000-575,000 Da), sodium bicarbonate, and ethylenediaminetetraacetic acid were obtained from Sigma-Aldrich Corp. (St Louis, MO). Riboflavin-5-phosphate was obtained from MP Biomedicals (Santa Ana, CA). Dulbecco phosphate-buffered saline solution (MgCl 2 and CaCl 2 free) was obtained from Life Technologies (Carlsbad, CA). All chemical solutions and buffers were prepared fresh using Millipore water (double-distilled, deionized water, r = 18.2 MV cm at 25°C) on the day of cross-linking.
All procedures were performed according to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research.
TXL With SMG
We performed chemical TXL with SMG using a method similar to that described in an earlier study. 13 Six intact cadaveric rabbit heads with clear corneas were obtained from the local abattoir within 1 hour postmortem. The central corneal thickness (CCT) was measured with an ultrasound pachymeter (Pachmate; DGH Technologies, PA). A single drop of proparacaine (0.5%) was applied to the corneal surface followed by epithelial removal using a crescent blade. An 8-mm Hessburg-Barron corneal vacuum reservoir (JEDMED, St Louis, MO) was then attached to the corneal surface. SMG solutions at a concentration equivalent to one quarter or one third the maximum allowed value (max = 39.1 mM or 0.5%, 1/4 max = 9.8 mM, and 1/3 max = 13 mM) were dissolved in a buffer solution containing 0.1 M NaHCO 3 (max = maximum allowed concentration in cosmetics and other personal care products as dictated by the European committee on cosmetics standards). The final solution of SMG was titrated to the desired pH 8.5 using a 0.1 N HCl solution. SMG solution was applied every 5 minutes over a 30-minute period. In other words, the cross-linking solution was changed every 5 minutes with fresh cross-linking solution to augment formaldehyde delivery to the tissues. The control contralateral eye was treated identically with vehicle after epithelial removal. Immediately after treatment, the eye was irrigated with balanced salt solution. A central 8mm corneal trephination was then performed. To include the only treated region and to ensure that we were considering effects related to the exposed/treated region (ie, to avoid transitional zones), we performed a 6-mm corneal punch (JEDMED) on the 8-mm treated button region, carefully, with the endothelium positioned facing upward.
Corneal Cross-Linking
Five intact cadaveric rabbit heads were used to conduct riboflavin-UVA photochemical corneal cross-linking (CXL) with similar methods. 14 CCT was measured with an ultrasound pachymeter. A single drop of proparacaine (0.5%) was applied. This was followed by removal of the corneal epithelium of a central 8-mm region using a crescent blade. The solution containing 0.1% riboflavin-5-phosphate solution in 1.1% HPMC was instilled on the debrided corneal surface for 5 minutes before UV treatment. UVA irradiation was performed using the Optos XLink Corneal Collagen Cross-Linking System (Optos, Dunfermline, UK) (370 nm, 3 mW/ cm 2 ) for 30 minutes. During irradiation, riboflavin solution was instilled every 3 minutes. At the end of the procedure, the eye was washed with balanced salt solution. The control contralateral eye was treated identically but without irradiation. As described above, a central 6-mm corneal trephined button was taken from the 8-mm area of epithelial debridement.
Ex Vivo Live-Dead Assay
In tissue culture plates, the 6-mm corneal buttons (paired samples) were stained with 2 mM calcein AM and 4 mM ethidium homodimer (The Live/Dead Kit; Molecular Probes Inc., Eugene, OR). Corneal buttons were always placed endothelial side up to decrease mechanical damage of the corneal endothelium. The plates were then placed in a 37°C, 5% CO 2 -humidified incubator for 45 minutes. Corneal buttons were immersed in phosphate-buffered saline and then placed between 2 coverslips. These samples were then analyzed by scanning laser confocal microscopy (Leica, Deerfield, IL) equipped with a fluorescence light source for detecting green and red fluorescent regions (Fluorovert; Leica).
Fluorescent images were captured using a Nikon A1 laser scanning confocal microscope on an Eclipse Ti stand (Nikon Instruments, Melville, NY) using a ·10/NA0.3 Plan Fluor Nikon objective for cell counting and ·20/NA0.75 Plan Apo Nikon objective for a higher magnification picture. Red and green fluorescence images were acquired sequentially to prevent bleed-through using standard lasers and emission filters: green (live cells, calcein AM) was excited at 488 nm with the corresponding emission collected from 500 to 550 nm and red (dead cells, ethidium homodimer-1) was excited at 561 nm with the corresponding emission collected from 570 to 620 nm. To further avoid taking images from the cut edges of the corneal button, a 4.5-mm central area was selected from the 6-mm button sample. Cells were counted using Fiji/ImageJ NIH software. 15 The cellular damage was calculated as the percentage of dead cells (red cells) from the total number of cells (red cells + green cells): 100 · red cells/ (red cells + green cells). The procedure used to estimate the number of dead and live cells was as follows: images acquired in red and green channels were first processed by applying an intensity threshold to the image so that the background fluorescence was removed. The number of dead cells was estimated from the red channel images by counting objects with the "Analyze Particles" function in Fiji. The number of live cells was then estimated from the green channel images by measuring the total area with cells and dividing it by the area of a single cell. Ten cells were manually selected and measured in each image to determine an average cell area. The measured average cell area was approximately 300 mm 2 . The total area of cell counting per cornea was 3.2 mm 2 , which was about one fifth of the area of the central 4.5-mm (15.9 mm 2 ) zone. Image collection, processing, and analysis were performed by Emilia Laura Munteanu, at the Confocal and Specialized Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University. After imaging, the cornea button was incubated in Optisol for 24-72 hours followed by differential scanning calorimetry (DSC) analysis.
Differential Scanning Calorimetry
Corneal buttons were removed from Optisol. After removal of excess Optisol solution, tissue samples were transferred to preweighed 50-mL aluminum pans. Peak thermal denaturation temperature (Tm) of all 6-mm corneal buttons was measured using a Perkin-Elmer DSC 6000 Autosampler (Waltham, MA). As previously discussed, the difference in thermal denaturation temperature (DTm) between the cross-linked sample and contralateral paired central sample was determined using the Pyris software (version 11.0; Perkin-Elmer) as previously reported. 13 
Statistical Analysis
Endothelial damage between cross-linked corneas and their paired controls was carried out using standard paired t tests. The mean CCT and DTm among groups were also compared using the Kruskal-Wallis test. The Statistical Package for the Social Sciences version 13.0 (SPSS Inc., Chicago, IL) was used for all statistical analyses. The significance value was P , 0.05.
RESULTS

Central Corneal Thickness
CCT measurements were taken before cross-linking in all samples. Limited information is available for post-crosslinking pachymetry. CCT is an indicator of corneal health, and as mentioned previously, the clinical recommendation for corneal thickness minima for CXL is 400 mm. Because the epithelium is 30 to 50 mm in thickness, corneal thickness at the time of CXL was below 400 mm. This may also in part explain the increased toxicity seen for CXL in this study.
The mean CCT before the procedure was 396 6 32 mm. The mean CCT values of control and CXL were 389 6 35 mm and 381 6 27 mm, respectively. The mean CCT was 410 6 33 mm (control) and 411 6 26 mm (1/4 max, 9.8 mM SMG). The mean CCT was 400 6 49 mm (control) and 390 6 40 mm (1/3 max, 13 mM SMG). The difference of mean CCT among groups was not statistically significant (Kruskal-Wallis test, P = 0.385). Figure 1 shows data obtained from the DSC analysis. The instrument has an expected degree of detection error of 60.3°C. The DTm after CXL was 2.2 6 0.9°C as determined by DSC. The shift after 1/4 max (9.8 mM) SMG treatment was 1.1 6 0.5°C. The shift after 1/3 max (13 mM) SMG treatment was 1.3 6 0.5°C (Fig. 1) . The difference of DTm among groups was not significant (Kruskal-Wallis test, P = 0.215).
Cross-Linking Effects as Determined by DSC
Endothelial Cell Toxicity
Endothelial cell toxicity was evaluated after crosslinking by staining the tissue using live-dead staining followed by confocal fluorescence microscopy imaging (Fig. 2) . Representative samples of both CXL-treated ( Fig. 3 ) and 1/4 max SMG treated ( Fig. 4 ) are included. In addition, identification of dead endothelial cells in the correct location was carried out using tangential sequential image selection with 3-dimensional reconstruction as shown in Figure 5 . In CXL-treated samples, the endothelial cell damage was 3 6 1.7% (control) and 8.9 6 11.1% (CXL). There was no significant difference for endothelial cell damage between the control and CXL samples (paired t test, P = 0.390). In 1/4 max-treated SMG samples, the endothelial cell damage was FIGURE 1. Corneal cross-linking effect of CXL versus TXL using SMG as determined by DSC. Peak thermal transition temperatures (Tm) were compared. Each sample was compared with its own control and the difference (or shift) in Tm was expressed as the DTm. The greatest effect was seen with CXL, followed by 1/3 max SMG and 1/4 max SMG. When combined with the cell toxicity data, we can evaluate the balance between "toxicity and fixation." Based on these results, we believe that this concentration would be an appropriate starting concentration for in vivo animal studies. 2.7 6 2.4% (control) and 2.8 6 2.2% (1/4 max, 9.8 mM SMG). In 1/3 max-treated SMG samples, the endothelial cell damage was 1 6 0.2% (control) and 19.5 6 32.2% (1/3 max, 13 mM SMG). The endothelial cell damage after SMG treatment at both concentrations was not significant when compared with control (paired t test, P = 0.938, P = 0.426, respectively).
Toxicity/Fixation
A simple index was developed to express the endothelial cell toxicity as a ratio of the efficacy of tissue fixation as determined by the shift in thermal denaturation Tm. For the toxicity value, the difference in toxicity percentages between the treated group and controls was used as the numerator and the difference in maximal thermal denaturation Tm between the treated group and the control (DTm) was used as the denominator. Using this simple fraction, we created values that represent the "toxicity/fixation" balance of a given cross-linking treatment. For CXL, 1/4 max, and 1/3 max, they were 2.7, 0.1, and 14, respectively. This, then, is a relative value that can be used to compare different treatment approaches.
DISCUSSION
The possibility of endothelial cell damage after CXL has been debated. In vitro and live animal studies have reported on endothelial toxicity after CXL. In endothelial culture experiments with 500 mM riboflavin and UVA irradiance of 0.4 mW/cm 2 , a significant cytotoxic effect on porcine corneal endothelial cells was observed. 16 In rabbits with mean corneal thickness of 330 mm, CXL (3 mW/cm 2 irradiance) resulted in complete loss of endothelium in the irradiated area. 17 In rabbit corneas with corneal thickness less than 400 mm, the endothelial UVA dose reached a cytotoxic level using the standard surface UVA dose of 5.4 J/cm 2 (3 mW/cm 2 ). 7 During a 4-year follow-up after CXL, the mean endothelial cell density remained unchanged in 17 patients with progressive keratoconus who had corneal thickness of at least 450 mm at the thinnest point before treatment. 18 In a different study, however, in which a total of 38 eyes of 38 patients with progressive keratoconus with a minimal corneal thickness of more than 400 mm were treated, the endothelial FIGURE 2. Endothelial damage from CXL versus TXL using SMG. Cells were imaged using a confocal fluorescence microscope after live-dead staining using calcein AM (red) and ethidium homodimer (green) (488 nm excitation/500-550 nm emission). The method for counting was as described in Methods and Materials. Each condition has its own paired control. All 3 sets of controls exhibited low levels of dead stained endothelial cells (,3%). SMG at 1/4 max (9.8 mM) was found to induce the least amount of endothelial damage (,3%). 1/3 max SMG was the most toxic (̴ 19%) but a significant sample variability was noted (̴ 30%). CXL showed intermediate endothelial damage at ̴ 8%. cell density (2373 6 580.7 cells/mm 2 ) 1 year postoperatively when compared with baseline values (2799 6 282.2 cells/ mm 2 ) (P = 0.07) was lower. 19 Corneal thickness is an important factor in irradiation toxicity. CXL in cornea less than 400 mm may be harmful to the endothelium. 8, 9 After CXL in thin corneas (corneal thickness less than 400 mm) and after epithelial removal, a significant decrease in endothelial cell density during a 12-month follow-up period (preoperative: 2733 6 180 cells/mm 2 , last follow-up visit: 2441 6 400 cells/mm 2 , P , 0.01) was noted. 8 Although CXL in corneas with thickness greater than 400 mm seems to be safe to the endothelium under current guidelines, there is possibility of localized endothelial damage, particularly if the UV irradiance source is not homogeneous. 9 SMG used in this study is a chemical preservative commonly used in cosmetics to prevent bacterial or fungal growth. SMG is also included in a commercially available eye drop to treat dry eyes in Europe (BluGelA; Sooft, Italy). In our previous study, SMG was shown to induce a good corneal stiffening effect in an ex vivo model and SMG at pH 8.5 showed the greatest upward shift in Tm. In this study, we also used SMG at pH 8.5. 13 TXL with SMG at a concentration of one-quarter max (max = maximum allowed concentration in cosmetics and other personal care products as dictated by the European committee on cosmetics standards) showed a collagen cross-linking effect by DSC with no corneal endothelial cell toxicity when compared to the paired, untreated control. TXL with SMG could provide an alternative cross-linking method, particularly in cases of thinner corneas.
One limitation of our study was the following: our result showed that CXL-induced cytotoxicity was less than that reported by Wollensak et al. 16 Although the mean percentage of dead endothelial cells was greater than that of controls in CXL samples, the results did not show a statistically significant difference when compared with controls. It is possible that we may have underestimated endothelial toxicity based on observations related to delayed-type apoptosis in UVexposed corneal endothelial cells. We checked for endothelial cell damage 90 minutes after the cross-linking (CXL or TXL) treatment. In a study in which live animals were killed at 4 hours after CXL treatment, no apoptotic endothelial cells were observed. However, the authors noted that maximum cytotoxic damage was found at 24 hours after UVA irradiation. This is known as "delayed type of apoptosis." 7, 20 Thus, the number of dead endothelial cells in our study may have been an underestimation because we could not account for "delayed apoptosis" under our experimental conditions. Another possibility is related to the differences in vehicles used for riboflavin photochemical cross-linking. The report by Wollensak et al 7 of endothelial cell toxicity applying the CXL procedure described in 2003 (in rabbit) used 20% high-molecular weight dextran (T-500), which is a traditional vehicle. We used a 1.1% HPMC solution. When compared with alternative vehicles such as methylcellulose and HPMC, high-molecular weight dextran produces reduced amounts of a "thick ocular surface film that increases UV light absorption." Thus, a thicker film produced by HPMC in our study could have "shielded" the endothelium, explaining our lower level of observed endothelial cell toxicity. 21 In this study, we looked for acute toxic effects rather than a delayed type of apoptosis. Rabbit endothelium has a greater ability to regenerate than in humans. We tried to stain and image as soon as possible after CXL or SMG treatment, eliminating the possibility of rabbit endothelial regeneration. In future in vivo studies, we will evaluate toxicity 24 hours after treatment to observe any delayed type of apoptosis and will also pursue longer term effects of toxicity after the cross-linking treatments.
Using confocal laser scanning fluorescence microscopy, we were able to see detailed images of the entire intact single layer of endothelium, and higher magnification pictures of fluorescent cells and 3-dimensional reconstructions (Fig. 5 ). We found that confocal laser scanning fluorescence microscopy coupled with live-dead staining provides a useful method to evaluate endothelial cell integrity. Confocal microscopy, particularly in conjunction with tissue autofluorescence and second harmonic-generated signals, 22 is being increasingly used in the evaluation of the cornea in diseases such as keratoconus 23 and after induced cross-linking. 24 We have also conducted studies using these related techniques, the results of which will be published later.
It seems clear that at the extremes of cross-linking conditions, cell toxicity and tissue fixation go hand in hand. That is, relatively high concentrations of cross-linking agents that induce significant biomechanically (or thermal stability) increased change will also induce widespread cytotoxicity. Similarly, very low levels of cross-linking reagents and/or photochemical reactions may neither kill any cells nor induce tissue stabilization. Clearly, there could be a wide range of "in-between" effects such that either cell toxicity or tissue fixation is favored during a treatment application. We hope to use this type of experimental setup to find conditions that maximize induced biomechanical effects and minimize cell toxicity. In this study, we identified an optimal concentration of chemical agent (SMG) that could induce a collagen crosslinking effect without inducing endothelial cell damage. Treating with SMG at 9.8 mM was safe when compared with paired controls as determined by cytotoxic effects to endothelial cells. In addition, a modest but consistent shift in Tm by DSC was shown. This study will lay the groundwork for future animal and human studies.
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